FGF2 and mesothelioma: In this study, expression data taken from a broad panel of mesothelioma cells and lung cancer cell lines demonstrated that high levels of FGF2 and/or FGFR1 RNA expression correlated with the antiproliferative effects of two FGF pathway inhibitors that differ in their mechanism of action.